INTRODUCTION
Pain is a common debilitating condition. Approximately 20% of patients and 25% to 50% of community-dwelling elders experience chronic pain. 1, 2 Although many studies have identified under-treatment of pain, [1] [2] [3] few have examined why providers vary in responding to patient-reported pain. 3, 4 Such information would help inform more successful approaches to pain management. In 2003, the Department of Veterans Affairs (VA) implemented the "5th vital sign"-a rating also known as the numeric rating scale (NRS) 3, 4 to assure routine pain assessment and improve management. 3, [5] [6] [7] [8] [9] The NRS asks veteran patients to rate current pain from zero or "no pain" to ten or "worst possible pain". 3, 6, 7 Moderate to severe pain, measured by a score on the NRS between four and ten, should typically trigger a comprehensive pain assessment and prompt intervention. 5 However, one study at a single VA medical center, found that routine pain screening did not change provider medication management. 3 That study occurred soon after implementing the 5th vital sign, using a pre-post design and did not examine the extent to which providers utilized the NRS for pain evaluation and management. This study builds on earlier work in developing an assessment across multiple sites with established NRS procedures and examines multiple processes of care, from assessment of pain to treatment. We examined indicators of four key processes of pain evaluation and management in a regional cohort of facilities where routine pain screening was implemented during the last 10 years. We estimated adherence to these indicators and examined patient and provider factors associated with these processes of care.
METHODS

Subjects and Setting
The Helping Veterans Experience Less Pain (HelpVets) study is a VA-funded cross-sectional cohort study designed to evaluate adherence to basic pain care management. We conducted the study from March 2006 to March 2007 in primary care, oncology, women's health and cardiology outpatient clinics at two VA hospitals and six associated clinics in the VA Greater Los Angeles Healthcare System.
Participants: Patients
We approached patients in the waiting areas of the outpatient study clinics; patients meeting inclusion criteria were invited to participate. Eligible patients were seen by participating providers, had vital signs taken during their visit, passed a brief cognitive screening test, spoke English, had intact hearing, had not previously participated and agreed to have their medical records reviewed. To assure an adequate number of subjects with possible pain-related conditions, we included all patients who reported fair or poor health, and every other patient who reported good (or better) health. In total, 6,138 patients were approached. Of those approached, 862 refused screening; 4,337 were ineligible (2, 265 had not yet had vital signs taken, 942 had not visited a provider, 310 visited nonparticipating clinics, 171 exhibited cognitive problems, 103 visited non-participating providers, 61 previously participated, 49 were hearing impaired). Of the remaining 939 eligible patients, 650 completed the patient baseline survey yielding a 69.2% response rate. Further details of the methods are elsewhere. 6 The present analysis includes the 140 patients reporting moderate to severe pain (an NRS of four or higher). 3, 5, [7] [8] [9] Patient Baseline Survey. The baseline survey asked patients about the degree to which pain was discussed during the nurse and provider visits, current treatment regimens and general quality of life issues.
Participants: Providers
Provider Baseline Survey. We asked all providers (n=260) in relevant clinics to complete a baseline survey about attitudes, beliefs, and practices prior to patient interviews. Of those approached, 209 (74%) completed surveys. This study includes 77 providers (45 staff physicians, nine fellows, five house staff, 14 nurse practitioners and four physician assistants) who cared for 140 patients in the analytic sample. Of the 77 providers, 57% had one patient, 17% had two patients, 14% had three patients, 10% had four patients and 1% had five patients.
Provider Post-visit Survey. After the patient visit, providers were asked to complete a post-visit survey that assessed provider's perception of, and discussion about patient's pain as well as whether they initiated or intensified a pharmacological intervention. If applicable, we queried about reasons for not changing treatment. Sixty-five of the 77 providers completed post-visit surveys for the 140 patients in the initial analytic sample, yielding valid post-visit provider data for 112 patients.
Additional Data Sources
Medical Record Review. Data elements for all four indicators were abstracted from clinic notes in the VA's electronic medical record (Computerized Patient Record System or CPRS) by one, experienced abstractor. To assure accuracy, the abstractor reviewed questionable records with physician investigators.
Pharmacy Data. We obtained pharmacy data from the regional data warehouse to supplement medical record estimates of pain regimen alteration. We identified pain medications dispensed within 90 days before and 90 days after each study visit. Of the 747 total prescriptions dispensed, 282 prescriptions were 24 unique agents used to treat pain including: acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), anti-seizure medicines used for analgesia, opioids and topical analgesics. A Ph.D. data abstractor characterized each prescription for each patient based on days of supply, dose, instructions and frequency of dispensing during the study. Increases in any of these factors resulted in an "increase" rating, while a decrease in any factors received a "decrease" rating. Prescriptions that remained consistent received a "no change" rating. After reviewing all medicines, each patient received an overall rating of "increase", "decrease", or "no change". A physician over-read 10% of all characteristics and to resolve any clinical difficulties that the abstractor faced. Of note, the available pharmacy data did not include non-VA pharmaceutical use.
Conceptual Framework
The Theory of Planned Behavior by Azjen and Fishbein explores the relationship between beliefs, attitudes, intentions and subsequent behavior. 10 It postulates that a person's attitude toward performing a behavior influences intent as do beliefs about the behavior by persons(s) who are important to the individual. [11] [12] [13] This theoretical model helps explain how provider beliefs, attitudes, and intentions may be important in understanding feelings about the NRS and responses to a moderate to severe pain rating. Provider attitudes toward a behavior (shaped by beliefs), subjective norms (determined by social standards), and provider perceived behavioral control about documenting and treating pain were all key constructs in evaluating determinants of pain management. However, it was infeasible to collect some variables in the framework and they were omitted from this analysis.
Measures: Dependent Variables (Quality Indicators)
The four quality indicators (QIs) evaluating pain assessment and management were adapted from the Assessing Care of Vulnerable Elders (ACOVE) [14] [15] [16] [17] [18] and Quality Assessment (QA) Tools measurement sets. 19, 20 Specifically, the four stem from the following recommendations for patients with moderate to severe pain on the NRS: 1. evaluate the presence or absence of pain; 2. evaluate the character of the pain; 3. note the degree of pain control; and 4. initiate or intensify pain treatment.
We assessed the degree to which providers adhered to each individual quality indicator, leaving interpretation deliberately liberal to meet the intent of the indicators. For example, any documentation of pain (or absence of pain) in the progress note met the first quality indicator. The character of pain included many terms such as type (e.g., throbbing, intermittent), location, and/or mitigating or worsening factors. General statements about improvement or stability of pain symptoms satisfied evaluation of pain control. Pharmacy prescriptions were carefully examined for initiation or intensification of pain management; we also assessed progress notes for advice on current prescriptions or over-the-counter medication(s).
Measures: Independent Variables and Covariates
Selection of independent variables representing provider and patient attitudes and demographics was guided by: 1. Literature review 1,3,13,21-24 ; 2. Conceptual framework 10-13 ; and 3.
Experts in palliative care and research. 19, 20, [25] [26] [27] [28] [29] [30] The independent variables included:
Provider attitudes toward pain management were measured by seven items with 5-point Likert response scales (strongly disagree to strongly agree): "patients are able to rate their own pain intensity on the 0-10 scale", "0-10 pain ratings by nurses accurately reflect the patient's pain intensity", "my patients want me to ask about their pain problems", "pain medication should be given when pain is severe", "pain can have negative consequences for a patient's functioning", "when reviewing patient's vital signs, I pay attention to their 0-10 pain score", and "patients are more satisfied when I address their pain concerns." We also queried about the percentage of provider's outpatients with painful conditions and collected information about the provider's race.
& Baseline patient variables
We controlled for substance abuse or musculoskeletal pain, and for patient age and race.
& Post-visit provider variables
The post-visit analytic variables included dichotomous questions (yes or no responses) that asked whether during the visit the provider: (1) noticed the nurse's NRS; (2) thought the patient was in pain; (3) talked about the symptom of pain; (4) had reasons for not discussing pain, as applicable (four different reasons); and (5) reasons for not initiating or intensifying treatment (five options). Institutional Review Board (IRB) approvals were obtained by the VA Greater Los Angeles Healthcare System and the VA Long Beach Healthcare System.
Analysis
We performed weighted bivariate logistic regressions to measure associations of the provider baseline variables with the four quality indicators. All associations with p-value <0.10 were included in multivariate analyses. We employed weighted logistic regressions fitting nested models by sequentially adding blocks of variables in StataSE 10.0. In each model, we first entered the block representing the provider attitude variables because we felt those variables were, conceptually, the most important for predicting the quality indicators. We then added a second block containing variables for two diagnoses (substance abuse and musculoskeletal pain), as these were previously identified as potential barriers in responding to pain. Patient and provider demographic variables (patient race and age, provider race) were added into the model last. The nested models were performed as a sensitivity analysis to confirm our model. We report the "full" model containing all variables.
In addition, we examined whether there were differences in provider reporting and medical record documentation by evaluating the percent of patients who received initiation or intensification of treatment (based on chart review) and compared that information to responses on the provider post-visit survey.
All analyses were weighted for patient survey non-response based on age, race, general health, cognition score, and adjusted for over-sampling of persons in fair to poor health. No adjustment for clustering by provider was needed given minimal variation in the number of patients per provider, with 74% of providers having one or two patients.
RESULTS
Most patient participants were non-Hispanic white (46.1%), African American (28.2%), or Hispanic (19.0%). Their mean age was 59.2 years and 95% were male. On chart review, 65 (46.1%) had a diagnosis of substance abuse and 90 (64.2%) had a diagnosis of musculoskeletal pain. On average, providers estimated that 40% of their patients had pain. Provider beliefs regarding pain are presented in Table 1 . Of the 140 patients who reported moderate to severe pain, the average pain score was 6.7. Table 2 presents scores for each quality indicator; Table 3 presents multivariate analysis.
Presence of Pain Noted
Providers were more likely to document the presence of pain if they believed that: "patients are able to rate their own pain intensity" (OR=2.02, p=0.01), "patients want him/her to ask about pain" (OR=3.49, p=0.01) or if "pain medications should be given when pain is severe" (OR=3.17, p=0.01). Providers were also more likely to document pain presence if they perceived a "pain rating as an important vital sign" (OR= 1.82, p=0.01) and "patients were more satisfied when they address pain concerns" (OR=2.41, p=0.02), but less likely to document pain for patients with substance abuse history (OR=.399, p=0.02). In multivariate analysis (Table 3) , two provider attitudes were significantly associated with the notation of pain presence: "patients want me to ask about pain" (OR=4.20, p=0.04) and "pain has negative consequences on patient functioning" (OR=7.10, p=0.01).
Character of Pain Noted
In bivariate analysis, documentation of pain character was found less often for patients who had a diagnosis of musculoskeletal pain (OR=0.25, p=0.01). In multivariate analysis, "patients are able to rate own pain intensity" was associated 
Degree of Pain Control Noted
In bivariate analyses, the following were associated with noting degree of pain control: provider's perception that patients could "accurately rate their pain intensity" (OR=2.03, p=0.01), the need for providing "pain medications when pain is severe" (OR= 2.83, p=0.01), pain having "negative consequences on patients' functioning" (OR=3.75, p=0.01), and paying "attention to 0-10 pain scores when reviewing patient vital signs" (OR=1.82, p= 0.04). Patient age was inversely associated with documenting pain control (OR=0.98, p=0.10). These relationships did not persist in multivariate analyses.
Pain Treatment Initiated or Intensified
Performance on this indicator was not significantly associated with any of the provider attitudes or other variables in either bivariate or multivariate analyses.
Post-visit Survey
Providers completed at least part of the post visit survey following 112 (80%) of patient visits. Providers reported they noticed the NRS during 67% of visits and in 64% of visits reported the patient was in pain. While medical record and pharmacy data review found documentation of treatment intensification in just 15% of visits, providers self-reported initiating or intensifying treatment at 48% of the visits. Thus, agreement between the two sources was poor (kappa=0.076, 95%CI=−0.1, 0.25).
Providers gave various reasons for not initiating or intensifying treatment for 40 such patients. The most common reason was that "the patient preferred not to change his/her current approach" (56%) followed by "everything has been done" (34.7%), "patient not experiencing pain" (26.0%), "patient misusing pain medication" (8.5%) and "patients not responding to previous treatments" (5.4%).
DISCUSSION
We found that among patients who reported moderate to severe pain at an appointment, providers often noted the presence of pain but did not clinically evaluate it further or modify pharmacologic treatment. Provider attitudes were weak predictors of adherence to quality indicators, although some provider attitudes toward the NRS were correlated with QI adherence.
Similar to prior studies, 3, 6, 25 our results question whether the 5th vital sign has substantively improved pain assessment and management. More notably, Mularski et al. 3 reported that [14] [15] [16] [17] [18] and were subjected to a rigorous development process. As such, the quality indicators allowed us to more broadly measure processes of care (i.e., notation, character and severity of pain). Second, Mularski et al. 3 conducted their study between 1999 and 2001, soon after the institution of the NRS when providers were perhaps not familiar with it. Our results, a decade later, suggest the screening tool still has had limited impact on pain management. Third, our work extends Mularski's findings from a single VA site to multiple sites. Why the 5th vital sign has not produced more substantive improvements is unclear. One possibility is the NRS does not accurately represent pain levels or that providers do not perceive it as accurate, and hence do not act based on the rating scale. Indeed, 12% of providers disagreed or strongly disagreed that "patients are able to rate their own pain intensity on the 0-10 scale" (Table 1) , suggesting concern with the tool. Another possibility is that providers do not approach pain evaluation uniformly. Chronic pain patients are vexing for many providers [22] [23] [24] [25] [26] and the subjective nature of pain likely adds to variance in addressing it. While rating pain numerically may create a standard measurement, it may not yield a standardized approach to its subsequent evaluation and management. Further research is needed on variations in pain management but, in the meantime, providers and patients might benefit from clinical decision support tools (e.g., clinical reminders) within CPRS. Measuring pain management poses unique methodological challenges. Chart review may not be optimal (for example, pharmacy records may not represent all provider actions), though it remains the current gold standard. However, our study looked for new or adjusted prescriptions within 90 days of a visit to evaluate for initiation or intensification. Even so, our results identified a divergence between providers' selfdescribed actions and pharmacy records. This could point to inaccurate information reflected in the pharmacy records, although this is unlikely within the VA. However, our pharmacy data did not include non-VA prescriptions and this may have importance since some patients, particularly those who have an $8 per month co-payment for each prescription, purchase medications privately. Several non-pharmaceutical intensification strategies were reported by patients to be useful (e.g., physical therapy, ice). Also, at times, initiation or intensification may not have been the most appropriate clinical action. When intensification did not occur at the visit, providers most commonly reported that patient preference was not to change treatment, "everything had been done", or the patient was not experiencing pain. Furthermore, visit based quality indicators may not be accurate proxies for measuring the quality of pain care at a single visit. Future research could consider longitudinal information to better understand factors influencing pain management. In addition, qualitative interview of providers may help to understand adherence to and predictors of the quality indicators. We examined only VA outpatients, limiting generalizability to other populations and healthcare systems. However, the VA is a leader in chronic care quality measurement 2, 3, 17, 20, 23, 24 and our study sites implemented routine pain screening a decade ago suggesting our findings represent a 'best case scenario.'
Our study provides greater understanding of how the 5th vital sign and providers' attitudes toward pain influence the quality of pain care. We found that simply implementing the NRS does not necessarily improve subsequent pain evaluation and management, as measured by four standardized quality indicators. Future research should examine what additional provider factors are associated with meeting the quality indicators and consider assessing non-pharmacologic interventions. Focused research could include bolstering the 5th vital sign beyond categorizing pain at one point in time; for example, additional screening question(s) [31] [32] [33] might address whether a patient's current regimen provides sufficient pain control. Whether adding such screening questions would improve pain management is unknown, but it appears that using the NRS scale alone does not guarantee high quality pain management.
